These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25447340)

  • 1. Measuring relief of dysphagia in locally advanced esophageal carcinoma patients submitted to high-dose-rate brachytherapy.
    Grazziotin Reisner R; Reisner ML; Ferreira MA; Rosa AA; Veras IM; Carneiro TM; Wolff B; Viégas CM; Mendonça de Araújo CM; Marchiori E
    Brachytherapy; 2015; 14(1):84-90. PubMed ID: 25447340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate brachytherapy for the palliation of malignant dysphagia.
    Homs MY; Eijkenboom WM; Coen VL; Haringsma J; van Blankenstein M; Kuipers EJ; Siersema PD
    Radiother Oncol; 2003 Mar; 66(3):327-32. PubMed ID: 12742273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer.
    Homs MY; Steyerberg EW; Eijkenboom WM; Siersema PD;
    Brachytherapy; 2006; 5(1):41-8. PubMed ID: 16563996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
    Hirdes MM; van Hooft JE; Wijrdeman HK; Hulshof MC; Fockens P; Reerink O; van Oijen MG; van der Tweel I; Vleggaar FP; Siersema PD
    Gastrointest Endosc; 2012 Aug; 76(2):267-74. PubMed ID: 22695208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy.
    Sharma V; Mahantshetty U; Dinshaw KA; Deshpande R; Sharma S
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):310-5. PubMed ID: 11872275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of esophagogastroscopy in application and follow-up of high-dose-rate brachytherapy (HDRB) for treatment of esophageal carcinoma.
    Greene FL; Boulware RJ; Bianco J
    Surg Laparosc Endosc; 1995 Dec; 5(6):425-30. PubMed ID: 8611986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraluminal brachytherapy in the treatment of oesophageal cancers--some preliminary results.
    Wee JT; Theobald DR; Chua EJ
    Ann Acad Med Singap; 1994 Mar; 23(2):226-30. PubMed ID: 7521615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
    Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
    Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curietherapy in the palliative treatment of esophageal cancer].
    Toulba A; Bakkali H; Boutayeb S; Kebdani T; Ahid S; Benjaafar N
    Pan Afr Med J; 2015; 20():59. PubMed ID: 26090017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [High-dose-rate brachytherapy in esophageal carcinoma: the Italian experience].
    Gava A; Fontan L; Bolner A; Botturi M; Cafaro I; Di Marco A; Marazzato G; Muto P; Orecchia R; Orsatti M; Parisi SS; Rigon A
    Radiol Med; 1996; 91(1-2):118-21. PubMed ID: 8614712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracavitary radiation in the treatment of advanced esophageal carcinoma: a comparison of high dose rate vs. low dose rate brachytherapy.
    Harvey JC; Fleischman EH; Bellotti JE; Kagan AR
    J Surg Oncol; 1993 Feb; 52(2):101-4. PubMed ID: 7682263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoluminal brachytherapy in the treatment of oesophageal cancer. Technique description, case report and review of the literature.
    Castilla L; Rovirosa Á; Ginés À; Pages M; Camacho C; Quilis C; Pereira V; Maurel J; Biete A
    Rev Esp Enferm Dig; 2015 Jul; 107(7):449-53. PubMed ID: 26140642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan.
    Kawamoto T; Nakamura N; Saito T; Tonari A; Wada H; Harada H; Kubota H; Nagakura H; Heianna J; Miyazawa K; Yamada K; Tago M; Fushiki M; Nozaki M; Uchida N; Araki N; Sekii S; Kosugi T; Takahashi T; Shikama N
    Jpn J Clin Oncol; 2021 May; 51(6):950-955. PubMed ID: 33624768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined stent insertion and single high-dose brachytherapy in patients with advanced esophageal cancer--results of a prospective safety study.
    Bergquist H; Johnsson E; Nyman J; Rylander H; Hammerlid E; Friesland S; Ejnell H; Lundell L; Ruth M
    Dis Esophagus; 2012 Jul; 25(5):410-5. PubMed ID: 21899654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachytherapy in oesophageal carcinoma.
    Leung JT; Kuan R
    Australas Radiol; 1995 Nov; 39(4):375-8. PubMed ID: 8561713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study.
    Sur RK; Levin CV; Donde B; Sharma V; Miszczyk L; Nag S
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):127-33. PubMed ID: 12007950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.